Busch Jeffrey 4
4 · THERALINK TECHNOLOGIES, INC. · Filed Sep 21, 2022
Insider Transaction Report
Form 4
Busch Jeffrey
Director
Transactions
- Award
Stock Option (right to buy)
2022-09-16+469,738,712→ 469,738,712 totalExercise: $0.00Exp: 2032-09-16→ Common Stock (469,738,712 underlying)
Footnotes (1)
- [F1]375,790,967 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 93,947,745 stock options will vest on May 1, 2023.